Skip to main content
Watch Insiders
RNTX filings

Corporate insider profile

Rickenbach Josef H Von Filing Activity

Latest reported as Director of Rein Therapeutics, Inc. (RNTX).

Purchase filings
1
Reported companies
1
Net open-market value
$49,559
Latest transaction
May 27, 2026

Affiliated corporations

Reported company relationships

RNTXLatest reported

Rein Therapeutics, Inc.

Director

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 27, 2026Rein Therapeutics, Inc. (RNTX)DirectorOpen Market Purchase47,060$1.05$49,559